Experiencia clínica del uso de adalimumab en el manejo de la hidradenitis supurativa. Comparando las tasas de respuesta con la enfermedad de Crohn
Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease
a Servicio de Dermatología, Hospital Punta de Europa, Algeciras, Cádiz, España
b Servicio de Gastroenterología, Hospital General Universitario Gregorio Marañón, Madrid, España
c Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, España
d Servicio de Dermatología, Hospital de Manises, Valencia, España
Leído
6852
Vecesse ha leído el artículo
2630
Total PDF
4222
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 74 | 115 | 189 |
| 2025 5 | 132 | 75 | 207 |
| 2025 4 | 112 | 51 | 163 |
| 2025 3 | 117 | 42 | 159 |
| 2025 2 | 135 | 59 | 194 |
| 2025 1 | 118 | 49 | 167 |
| 2024 12 | 107 | 31 | 138 |
| 2024 11 | 96 | 59 | 155 |
| 2024 10 | 74 | 51 | 125 |
| 2024 9 | 73 | 25 | 98 |
| 2024 8 | 90 | 46 | 136 |
| 2024 7 | 63 | 32 | 95 |
| 2024 6 | 107 | 31 | 138 |
| 2024 5 | 69 | 30 | 99 |
| 2024 4 | 72 | 45 | 117 |
| 2024 3 | 76 | 35 | 111 |
| 2024 2 | 94 | 32 | 126 |
| 2024 1 | 85 | 42 | 127 |
| 2023 12 | 79 | 27 | 106 |
| 2023 11 | 112 | 50 | 162 |
| 2023 10 | 76 | 38 | 114 |
| 2023 9 | 50 | 28 | 78 |
| 2023 8 | 74 | 24 | 98 |
| 2023 7 | 72 | 42 | 114 |
| 2023 6 | 53 | 37 | 90 |
| 2023 5 | 86 | 33 | 119 |
| 2023 4 | 59 | 21 | 80 |
| 2023 3 | 65 | 34 | 99 |
| 2023 2 | 78 | 26 | 104 |
| 2022 1 | 46 | 37 | 83 |
| 2022 12 | 37 | 36 | 73 |
| 2022 11 | 49 | 43 | 92 |
| 2022 10 | 41 | 37 | 78 |
| 2022 9 | 48 | 45 | 93 |
| 2022 8 | 59 | 46 | 105 |
| 2022 7 | 31 | 54 | 85 |
| 2022 6 | 49 | 35 | 84 |
| 2022 5 | 67 | 37 | 104 |
| 2022 4 | 36 | 32 | 68 |
| 2022 3 | 39 | 66 | 105 |
| 2022 2 | 38 | 42 | 80 |
| 2021 1 | 54 | 52 | 106 |
| 2021 12 | 47 | 44 | 91 |
| 2021 11 | 42 | 45 | 87 |
| 2021 10 | 41 | 55 | 96 |
| 2021 9 | 39 | 40 | 79 |
| 2021 8 | 52 | 27 | 79 |
| 2021 7 | 37 | 25 | 62 |
| 2021 6 | 50 | 41 | 91 |
| 2021 5 | 54 | 49 | 103 |
| 2021 4 | 135 | 103 | 238 |
| 2021 3 | 58 | 42 | 100 |
| 2021 2 | 45 | 30 | 75 |
| 2020 1 | 33 | 36 | 69 |
| 2020 12 | 48 | 28 | 76 |
| 2020 11 | 43 | 27 | 70 |
| 2020 10 | 42 | 14 | 56 |
| 2020 9 | 44 | 19 | 63 |
| 2020 8 | 45 | 31 | 76 |
| 2020 7 | 56 | 33 | 89 |
| 2020 6 | 56 | 38 | 94 |
| 2020 5 | 49 | 25 | 74 |
| 2020 4 | 31 | 20 | 51 |
| 2020 3 | 32 | 34 | 66 |
| 2020 2 | 6 | 4 | 10 |
| 2019 12 | 0 | 2 | 2 |
| 2019 8 | 1 | 0 | 1 |
| 2019 5 | 1 | 3 | 4 |
| 2019 4 | 1 | 6 | 7 |
| 2019 3 | 1 | 0 | 1 |
| 2019 2 | 0 | 8 | 8 |
| 2018 11 | 2 | 4 | 6 |
| 2018 10 | 0 | 4 | 4 |
| 2018 9 | 0 | 2 | 2 |
| 2018 5 | 0 | 2 | 2 |
| 2018 4 | 1 | 1 | 2 |
| 2018 3 | 0 | 2 | 2 |
| 2018 2 | 4 | 1 | 5 |
| 2018 1 | 3 | 1 | 4 |
| 2017 12 | 3 | 0 | 3 |
| 2017 11 | 7 | 0 | 7 |
| 2017 10 | 2 | 0 | 2 |
| 2017 9 | 3 | 1 | 4 |
| 2017 8 | 3 | 1 | 4 |
| 2017 7 | 1 | 2 | 3 |
| 2017 6 | 3 | 0 | 3 |
| 2017 5 | 1 | 0 | 1 |
| 2017 4 | 3 | 2 | 5 |
| 2017 3 | 2 | 1 | 3 |
| 2017 2 | 1 | 3 | 4 |
| 2016 1 | 2 | 2 | 4 |
Mostrar todo
